<DOC>
	<DOCNO>NCT01581333</DOCNO>
	<brief_summary>Clinical trial intend reduce antibiotic therapy duration `` in-hospital '' patient haematological disease develop fever low white blood cell count ( neutropenia ) .</brief_summary>
	<brief_title>Study Reduce Duration Antibiotic Therapy Haematological Patients With Fever Neutropenia</brief_title>
	<detailed_description>The optimal duration empirical antimicrobial therapy ( AT ) hematological patient febrile neutropenia ( FN ) unknown . The Infectious Diseases Society America ( IDSA ) recommend maintain AT least neutropenia recover , literally `` year experience proven approach safe effective '' . This recommendation likely cause unnecessarily prolong treatment , urgent need optimize antimicrobial therapy propose IDSA . The main objective study establish whether individualized clinical protocol well standard criterion ( recovery neutropenia criterion suspend empirical AT hematological patient FN ) .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Adult patient ( equal old 18 year ) sex admit Department Clinical Hematology develop febrile neutropenia . Including fever unknown source fever secondary infection focus clinical diagnosis without laboratory confirmation . Informed consent sign . Fever etiologic diagnosis . Patients epilepsy . Pregnant lactating woman . Patients HIV infection . Patients severe renal failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>febrile neutropenia</keyword>
	<keyword>antimicrobial treatment</keyword>
	<keyword>procalcitonin</keyword>
</DOC>